Archive for February, 2013
-
Macromolecular Prodrugs of Ribavirin Combat Side Effects and Toxicity with No Loss of Activity of the Drug
The first publication outlining our efforts to utilize polymer therapeutics in antiviral therapy has been published in Chemical Communications. The article is entitled “Macromolecular Prodrugs of Ribavirin Combat Side Effects […]
![The first publication outlining our efforts to utilize polymer therapeutics in antiviral therapy has been published in Chemical Communications. The article is entitled “Macromolecular Prodrugs of Ribavirin Combat Side Effects […]](http://www.zelikin-lab.com/wp-content/uploads/2013/02/RBV-and-RBCs-195x110.png "Macromolecular Prodrugs of Ribavirin Combat Side Effects and Toxicity with No Loss of Activity of the Drug")
![“Chemical zymogens for the protein cysteinome“ https://doi.org/10.1038/s41467-022-32609-1 We present three classes of chemical zymogens established around the protein cysteinome. In each case, the cysteine thiol group was converted into a […]](http://www.zelikin-lab.com/wp-content/uploads/2022/08/image-36x36.png "New publication from the team in Nature Communications!"){kind=small}